Compare Exelixis Inc. Common Stock (EXEL) vs Spotify Technology (SPOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Exelixis Inc. Common Stock vs Spotify Technology — how do they compare? Exelixis Inc. Common Stock trades at $59.92 (market cap $14.62B), while Spotify Technology trades at $525.65 (market cap $108.22B). The key difference: Spotify Technology is far larger — about 7.4× Exelixis Inc. Common Stock's market cap, and Exelixis Inc. Common Stock is trading nearer its 52-week high, Spotify Technology nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and Spotify Technology for 111 Days on average.
| EXEL | SPOT | |
|---|---|---|
Market Cap | $14.62B | $108.22B |
Volume | 2,684,957 | 1,655,796 |
Sector | Health | Media |
52-Week High | $59.13 | $692.04 |
52-Week Low | $34.54 | $412.75 |
Typical Hold Time | 0 Days | 111 Days |
Enterprise Value | $13.95B | $98.23B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Spotify (SPOT) trades at $524.71, up 2.3% with strong technical momentum and bullish moving averages. The company demonstrates robust fundamental improvement with revenue growing from $11.7B in 2022 to $17.2B in 2025, while achieving profitability with net income of $2.2B. Recent earnings show mixed results with Q2 2026 missing expectations, but analyst sentiment remains positive with 62% buy ratings and a $606.50 consensus price target.
The outlook remains favorable with continued revenue growth and margin expansion driving upside potential. Key risks include competitive pressures in streaming and market volatility. With strong institutional support and improving cash flow trends, SPOT presents a growth opportunity despite recent technical overbought conditions near resistance levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Exelixis Inc. Common Stock
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →About Spotify Technology
Spotify Technology S.A. provides music streaming services. The Company offers commercial-free music and ad-supported services to subscribers. Spotify Technology serves clients worldwide.
Read more on SPOT →
